Changes in the structure and function of normal cellular genes lie at the heart of carcinogenesis. The work supported by this grant seeks to identify cellular genes responsible for cancerous growth, the means by which carcinogens bring these genes into play, and the biochemical mechanisms by which the genes act. If the search succeeds, it should provide new and more rational strategies for the prevention, diagnosis and therapy of cancer; and it should also reveal principles by which the normal growth and development of cells are controlled. The work is conducted primarily with retroviruses, whose tumorigenic potentials represent a microcosm of carcinogenesis. Some of these viruses carry """"""""oncogenes"""""""" that directly convert cells to neoplastic growth. Other retroviruses do not possess oncogenes but instead induce tumors by mutating the DNA of host cells. Both forms of tumorigenesis by retroviruses offer access to cellular genes that may contribute to neoplastic growth: the oncogene of retroviruses are partial or complete copies of normal cellular genes (""""""""proto-oncogenes""""""""), tranduced into the viruses by accident during the course of evolution; and the mutagenesis of cellular DNA by retroviruses activates genes that can also be regarded as proto-oncogenes. A suite of avian retroviruses is used that, in the aggregate, provides experimental models for most of the major forms of cancer. Among these viruses are represented five oncogenes (v-src, v-fps, v-myc, v-erb-B, and v-myb) that are major objects of study. Experimental strategies are aimed at identifying the proteins encoded by oncogenes and proto-oncogenes; determining the functions of these proteins in their normal guise; discerning changes in their function that may account for tumorigenesis; identifying cellular functions whose perversion by oncogenes are involved in the genesis of human tumors; and exploiting the discovery of proto-oncogenes to perform genetic and biochemical analyses of how the growth and differentiation of normal cells is controlled. Methods include molecular cloning; nucleotide sequencing; DNA-mediated gene transfer; preparation of both polyclonal and monoclonal antibodies; immunoprecipitation; immunofluorescence and electron microscopy; purification and chemical analysis of proteins; site-directed mutagenesis with recombinant; and genetic analyses with both Drosophila melanogaster and Saccharomyces cerevisiae.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA012705-15
Application #
3163674
Study Section
Virology Study Section (VR)
Project Start
1976-06-30
Project End
1990-02-28
Budget Start
1986-03-01
Budget End
1987-02-28
Support Year
15
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Chen, X; Kang, H; Shen, L X et al. (1996) A characteristic bent conformation of RNA pseudoknots promotes -1 frameshifting during translation of retroviral RNA. J Mol Biol 260:479-83
Chen, X; Chamorro, M; Lee, S I et al. (1995) Structural and functional studies of retroviral RNA pseudoknots involved in ribosomal frameshifting: nucleotides at the junction of the two stems are important for efficient ribosomal frameshifting. EMBO J 14:842-52
Shen, L X; Tinoco Jr, I (1995) The structure of an RNA pseudoknot that causes efficient frameshifting in mouse mammary tumor virus. J Mol Biol 247:963-78
Levin, D E; Bishop, J M (1990) A putative protein kinase gene (kin1+) is important for growth polarity in Schizosaccharomyces pombe. Proc Natl Acad Sci U S A 87:8272-6
Levin, D E; Fields, F O; Kunisawa, R et al. (1990) A candidate protein kinase C gene, PKC1, is required for the S. cerevisiae cell cycle. Cell 62:213-24
Bruskin, A; Jackson, J; Bishop, J M et al. (1990) Six amino acids from the retroviral gene gag greatly enhance the transforming potential of the oncogene v-erb-B. Oncogene 5:15-24
Hay, N; Takimoto, M; Bishop, J M (1989) A FOS protein is present in a complex that binds a negative regulator of MYC. Genes Dev 3:293-303
Wright, S; Bishop, J M (1989) DNA sequences that mediate attenuation of transcription from the mouse protooncogene myc. Proc Natl Acad Sci U S A 86:505-9
Wells, A; Bishop, J M (1988) Genetic determinants of neoplastic transformation by the retroviral oncogene v-erbB. Proc Natl Acad Sci U S A 85:7597-601
Wells, A; Bishop, J M; Helmeste, D (1988) Amplified gene for the epidermal growth factor receptor in a human glioblastoma cell line encodes an enzymatically inactive protein. Mol Cell Biol 8:4561-5

Showing the most recent 10 out of 38 publications